Trials / Completed
CompletedNCT04874285
Use of Dietary Supplements in Patients at Risk of Abortion Treated With Progesterone.
Supplementation With Hyaluronic Acid, Alpha-lipoic Acid, Magnesium, and Vitamin D and B6 in Patients at Risk of Abortion Treated With Progesterone: a Pilot Study.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 63 (actual)
- Sponsor
- Lo.Li.Pharma s.r.l · Industry
- Sex
- Female
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The trial aims to investigate the effect of supplementation with hyaluronic acid, alpha-lipoic acid, magnesium, vitamin D and vitamin B6 in progesterone-treated pregnant women with risk factors for abortion.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | HA | hyaluronic acid, alpha-lipoic acid, vitamin D and vitamin B6 |
Timeline
- Start date
- 2021-05-03
- Primary completion
- 2022-05-30
- Completion
- 2023-05-11
- First posted
- 2021-05-05
- Last updated
- 2023-11-03
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT04874285. Inclusion in this directory is not an endorsement.